HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Helen of Troy Q2

This article was originally published in The Rose Sheet

Executive Summary

Personal care sales rose 10% to $111 mil. during the second quarter (ended Aug. 31), and grew 7.4% to $216.3 mil. for the first half of the year, firm reports Oct. 5. Net sales in Q2 were up 12.9% to $147.2 mil., while net earnings advanced 15% to $10.9 mil. Results were positively impacted by the initial sell-through of new products at retail, Helen of Troy says. Net revenues in the first half of the year increased 7.7% to $277.6 mil., while net earnings fell 12.2% to $17.6 mil. Helen of Troy reaffirmed its previous guidance projecting full-year (ending Feb. 28) revenues will be in the range of $600 mil.-$620 mil. (1"The Rose Sheet" May 15, 2006, p. 8)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel